Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients

Carcinogenesis

Volumn 26, Issue 1, 2005, Pages 185-191

  Fryer, Anthony A ^a   Ramsay, Helen M ^b   Lovatt, Tracy J ^a   Jones, Peter W ^c   Hawley, Carmel M ^d   Nicol, David L ^d   Strange, Richard C ^a   Harden, Paul N ^b  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MYCOPHENOLIC ACID; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELISM; ARTICLE; AUSTRALIA; BINOMIAL DISTRIBUTION; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG MEGADOSE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; UNITED KINGDOM;

ADULT; AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; PREDNISOLONE; RISK FACTORS; SKIN NEOPLASMS; SMOKING; ULTRAVIOLET RAYS;

EID: 13444251574     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh291     Document Type: Article

References (34)

1. Strange,R.C. and Fryer,A.A. (1999) The glutathione S-transferases: influence of polymorphism on susceptibility to non familial cancers. In Boffetta,P., Caporaso,N., Cuzick,J., Lang,M. and Vineis,P. (eds) Metabolic Polymorphisms and Cancer. IARC Scientific Publications, IARC, Lyon, pp. 303-322.
2. Ramachandran,S., Fryer,A.A., Lovatt,T., Lear,J., Smith,A.G. and Strange,R.C. (2001) Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype. J. Photochem. Photobiol. B, 63, 1-7.
3. Heagerty,A.H., Fitzgerald,D., Smith,A., Bowers,B., Jones,P., Fryer,A.A., Zhao,L., Alldersea,J. and Strange,R.C. (1994) Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet, 343, 266-268.
4. Yengi,L., Inskip,A., Gilford,J. et al. (1996) Polymorphism at the glutathione S-transferase, GSTM3 locus: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res., 56, 1974-1977.
5. Lear,J.T., Smith,A.G., Bowers,B., Heagerty,A.H.M., Jones,P.W., Gilford,J., Alldersea,J., Strange,R.C and Fryer,A.A. (1997) Tumor site in cutaneous basal cell carcinoma: influence of glutathione S-transferase, GSTT1 and cytochrome P450, CYP1A1 genotypes and their interactions. J. Invest. Dermatol., 108, 519-522.
6. Ramsay,H.M., Fryer,A.A., Smith,A.G. and Harden,P.N. (2000) Clinical risk factors associated with non-melanoma skin cancer in renal transplant recipients. Am. J. Kidney Dis., 36, 167-176.
7. Ramsay,H.M., Fryer,A.A., Hawley,C.M., Smith,A.G., Nicol,D.L. and Harden,P.N. (2003) Factors associated with non-melanoma skin cancer following renal transplantation in Queensland, Australia. J. Am. Acad. Dermatol., 49, 397-406.
8. Kasiske,B.L., Vazquez,M.A., Harmon,W.E., Brown,R.S., Danovitch,G.M. and Gaston,R.S. (2000) Recommendations for the outpatient surveillance of renal transplant recipients. J. Am. Soc. Nephrol., 11, S1-S86.
9. Recce,S.M., Harden,P.N., Smith,A.G. and Ramsay,H.M. (2002) A model for nurse-led skin cancer surveillance following renal transplantation. Nephrol. Nurs. J., 29, 257-260.
10. Harden,P.N., Fryer,A.A., Reece,S., Smith,A.G. and Ramsay,H.M. (2001) Annual incidence and predicted risk of non-melanoma skin cancer in renal transplant recipients. Transplant Proc., 33, 1302-1304.
11. Carroll,R.P., Ramsay,H.M., Fryer,A.A., Hawley,C.M., Nicol,D.L. and Harden,P.N. (2003) Incidence and prediction of non melanoma skin cancer post-renal transplant: a prospective study in Queensland Australia. Am. J. Kidney Dis., 41, 676-683.
12. Bouwes Bavinck,J.N., Hardie,D.R., Green,A., Cutmore,S., MacNaught,A., O'Sullivan,B., Siskind,V., Van Der Woude,F.J. and Hardie,I.R. (1996) The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation, 61 715-721.
13. Hardie,I.R. (1995) Skin cancer in transplant recipients. Transplant Rev., 9, 1-16.
14. McGregor,J.M., Berkhout,R.J., Rozycka,M., ter Schegget,J., Bouwes Bavinck,J.N., Brooks,L. and Crook,T. (1997) p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene, 15, 1737-1740.
15. Ziegler,A., Leffell,D.J., Kunala,S. et al. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl Acad. Sci. USA, 90, 4216-4220.
16. Lear,J.T., Smith,A.G., Strange,R.C. and Fryer,A.A. (2000) Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br. J. Dermatol., 142, 8-15.
17. Ramsay,H.M., Harden,P.N., Reece,S., Smith,A.G., Jones,P.W., Strange,R.C. and Fryer,A.A. (2001) Polymorphisms in glutathione S-transferases are associated with altered risk of non-melanoma skin cancer in renal transplant recipients: a preliminary analysis. J. Invest. Dermatol., 117, 251-255.
18. Marshall,S.E., Bordea,C., Haldar,N.A., Mullighan,C.G., Wojnarowska,F., Morris,P.J. and Welsh,K.I. (2000) Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int., 58, 2186-2193.
19. Colhoun,H.M., McKeigue,P.M. and Davey Smith,G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865-872.
20. Cardon,L.R. and Palmer,L,J. (2003) Population stratification and spurious allelic associations. Lancet, 361, 598-600.
21. Karagas,M.R., Cushing,G.L. Jr, Greenberg,E.R., Mott,L.A., Spencer,S.K. and Nierenberg,D.W. (2001) Non-melanoma skin cancers and glucocorticoid therapy. Br. J. Cancer, 85, 683-686.
22. Sorensen,H.T., Mellemkjaer,L., Nielsen,G.L., Baron,J.A., Olsen,J.H. and Karagas,M.R. (2004) Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J. Natl Cancer Inst., 96, 709-711.
23. Hayes,J.D. and Pulford,D.J. (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol., 30, 445-600.
24. Ramsay,H.M., Fryer,A.A., Hawley,C.M., Smith,A.G., Nicol,D.L. and Harden,P.N. (2002) Non-melanoma skin cancer risk in the Queensland renal transplant population. Br. J. Dermatol., 147, 950-956.
25. Miller,S.A., Dykes,D.D. and Polesky,H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
26. Elexpuru-Camiruaga,J., Buxton,N., Kandula,V. et al. (1996) Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase, GSTT1 and GSTM1 and cytochrome P450, CYP2D6 loci. Cancer Res., 55, 4237-4239.
27. Inskip,A., Elexperu-Camiruaga,J., Buxton,N. et al. (1995) Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem. J., 312, 713-716.
28. Fryer,A.A., Bianco,A., Hepple,M., Alldersea,J., Jones,P.W., Strange,R.C. and Spiteri,M.A. (2000) Polymorphism at the glutathione S-transferase, GSTP1, locus: A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med., 161, 1437-1442.
29. Perneger,T.V. (1998) What's wrong with Bonferroni adjustments. Br. Med. J., 316, 1236-1238.
30. Rosenberger,W.F. (1996) Dealing with multiplicities in pharmacoepidemiological studies. Pharmacoepidemiol. Drug Safety, 5, 95-100.
31. Adler,V., Yin,Z., Fuchs,S.Y. et al. (1999) Regulation of JNK signalling by GSTp. EMBO J., 18, 1321-1334.
32. Townsend,D.M. and Tew,K.D. (2003) Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am. J. Pharmacogenomics, 3, 157-172.
33. Hu,X., Xia,H., Srivastava,S.K., Herzog,C., Awasthi,Y.C. Ji,X., Zimniak,P. and Singh,S.V. (1997) Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun., 238, 397-402.
34. Watson,M.A., Stewart,R.K., Smith,G.B.J., Massey,T.E. and Bell,D.A. (1998) Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, 275-280.